SOLICITATION NOTICE
65 -- BRILLIANT VIOLET ANTI-HUMAN ANTIBODIES
- Notice Date
- 4/26/2022 1:45:58 PM
- Notice Type
- Solicitation
- NAICS
- 325414
— Biological Product (except Diagnostic) Manufacturing
- Contracting Office
- NATIONAL INSTITUTES OF HEALTH NIAID BETHESDA MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- RFQ-NIAID-2119014
- Response Due
- 5/11/2022 9:00:00 AM
- Archive Date
- 05/26/2022
- Point of Contact
- Maliaka Pinkney, Phone: 2406695308, Julienne Keiser, Phone: 4063639370
- E-Mail Address
-
maliaka.pinkney@nih.gov, jkeiser@niaid.nih.gov
(maliaka.pinkney@nih.gov, jkeiser@niaid.nih.gov)
- Description
- This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 �Streamlined Procedures for Evaluation and solicitation for commercial Items,� as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-2119014 and the solicitation is issued as a Request for Quotes (RFQ). This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2021-03 February 19, 2021. The North American Industry Classification System (NAICS) code for this procurement is 325414, BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING, with a small business size standard of 1250 employees. The requirement is being competed as a brand name, full and open competition, without a small business set-aside. The National Institute of Allergy and Infectious Diseases (NIAID) has a requirement for reagents used to examine blood and tissue derived immune cell subtypes and the cytokines they produce in animal studies where specimens have been exposed COVID-19. The samples acquired from these studies will be analyzed both pre- and post-vaccination as well as pre- and post-infection. Ultimately, the results of these studies support the specific mission of the National Institute of Allergy and Infectious Disease to understand the pathology, progression, and disease mechanisms of COVID-19 by better understanding the underlying immunologic response with the hope of justifying the use of specific vaccines and vaccine dosing regiments. The following antibodies are required: 1. Catalog# 302332, Manufacture: Biolegend, Brilliant Violet 570 anti-human CD20, Qty. 20 2. Catalog# 301038, Manufacture: Biolegend, Brilliant Violet 570 anti-human CD8a, Qty. 20 3. Catalog# 512326, Manufacture: Biolegend, Brilliant Violet 605 anti-human IL-17A, Qty. 50 4. Catalog# 353234, Manufacture: Biolegend, Brilliant Violet 650 anti-human CD197 (CCR7), Qty. 100 5. Catalog# 302828, Manufacture: Biolegend, Brilliant Violet 650 anti-human CD27, Qty. 50 6. Catalog# 301840, Manufacture: Biolegend, Brilliant Violet 785 anti-human CD14, Qty. 10 Place of Performance: NIH, 9 West Watkins Mill Rd, Gaithersburg, MD 20878, United States. FOB: Destination The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The award will be based on the following: technical capability to meet the requirements and price. The following FAR provisions apply to this acquisition: FAR 52.212-1 Instructions to Offerors Commercial Items (June 2020) FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (AUG 2020) FAR 52.204-7 System for Award Management (Oct 2018) (Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record) FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements � Representation (Jan 2017) 52.204�24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-24 The following FAR contract clauses apply to this acquisition: FAR 52-212-4 Contract Terms and Conditions Commercial Items (OCT 2018) FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (JAN 2022) *The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting. FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (Dec 2013) FAR 52.204-13 System for Award Management Maintenance (Oct 2018) HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 2015) 52.252-2 -- Clauses Incorporated by Reference. (Feb 1998) This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: http://farsite.hill.af.mil/vffara.htm By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov). Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax. Submission shall be received not later than May 11, 2022 @ 12:00 PM EST Offers may be e-mailed to Maliaka Pinkney (E-Mail/maliaka.pinkney@nih.gov). Offers shall include RFQ number in the subject line (RFQ-NIAID-2119014). Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f) All responsible sources may submit an offer that will be considered by this Agency. Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Maliaka Pinkney @ maliaka.pinkney@nih.gov.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/2d9fce01c09948789cb196d788400a53/view)
- Place of Performance
- Address: Gaithersburg, MD 20878, USA
- Zip Code: 20878
- Country: USA
- Zip Code: 20878
- Record
- SN06308623-F 20220428/220426230115 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |